Prothena Plc Correlations

PRTA Stock  USD 8.88  0.09  1.00%   
The current 90-days correlation between Prothena plc and Kalvista Pharmaceuticals is 0.37 (i.e., Weak diversification). The correlation of Prothena Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Prothena Plc Correlation With Market

Excellent diversification

The correlation between Prothena plc and DJI is -0.68 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Prothena plc and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

Moving together with Prothena Stock

  0.74VCYT VeracytePairCorr
  0.76DRMA Dermata TherapeuticsPairCorr
  0.83DTIL Precision BioSciencesPairCorr

Moving against Prothena Stock

  0.72EQ EquilliumPairCorr
  0.61GXEA Galapagos NVPairCorr
  0.458VP1 AVRICORE HEALTH INCPairCorr
  0.43VALN Valneva SE ADRPairCorr
  0.35CMB Cambium BioPairCorr
  0.76DRTS Alpha Tau Medical Earnings Call Next WeekPairCorr
  0.70P6S Bayer AG NA Earnings Call This WeekPairCorr
  0.566C1 CytomX Therapeutics Earnings Call Next WeekPairCorr
  0.37DRUG Bright Minds BiosciencesPairCorr
  0.37PYC Physiomics Plc Earnings Call This WeekPairCorr
  0.35DSGN Design TherapeuticsPairCorr
  0.31VERA Vera TherapeuticsPairCorr
  0.64ALA Arovella TherapeuticsPairCorr
  0.63VNDA Vanda Pharmaceuticals TrendingPairCorr
  0.58DVAX Dynavax TechnologiesPairCorr
  0.42HDP1 Arrowhead PharmaceuticalsPairCorr
  0.4VINC Vincerx Pharma CommonPairCorr
  0.32NANO Nanobiotix SAPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RIGLVSTM
GOSSBCYC
CRVSVTYX
GOSSVSTM
RIGLBCYC
VSTMBCYC
  

High negative correlations

VTYXVSTM
RIGLCRVS
RIGLVTYX
GOSSVTYX
NMRABCYC
GOSSNMRA

Risk-Adjusted Indicators

There is a big difference between Prothena Stock performing well and Prothena Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prothena Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KALV  2.83  0.15  0.04  0.22  3.46 
 6.17 
 20.72 
BCYC  2.73 (0.22) 0.00 (0.06) 0.00 
 6.06 
 14.20 
FDMT  3.66  0.22  0.00 (0.13) 5.81 
 7.15 
 27.09 
VSTM  3.27 (0.71) 0.00 (0.73) 0.00 
 5.83 
 19.78 
OLMA  3.48  0.35  0.08  0.60  3.65 
 8.41 
 24.77 
VTYX  3.22  0.80  0.16 (4.23) 3.05 
 9.00 
 37.04 
NMRA  4.18  0.59  0.13  1.34  3.57 
 10.98 
 33.25 
CRVS  6.56  2.88  0.48 (0.33) 3.42 
 7.35 
 174.42 
GOSS  5.08 (2.25) 0.00 (0.45) 0.00 
 7.66 
 94.66 
RIGL  2.75 (0.35) 0.00 (0.17) 0.00 
 6.18 
 19.03 

Prothena Plc Corporate Management

Hideki MDChief OfficerProfile
CPA CPAChief ControllerProfile
Jennifer ZibudaDirector CommunicationProfile
Brandon SmithChief OfficerProfile
Wagner ZagoChief Scientific OfficerProfile
Carol KarpChief Regulatory OfficerProfile
David FordChief OfficerProfile